Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Gastroenterology ; 161(3): 982-995.e2, 2021 09.
Artigo em Inglês | MEDLINE | ID: mdl-34051238

RESUMO

BACKGROUND & AIMS: Heavy alcohol consumption is a common cause of acute pancreatitis; however, alcohol abuse does not always result in clinical pancreatitis. As a consequence, the factors responsible for alcohol-induced pancreatitis are not well understood. In experimental animals, it has been difficult to produce pancreatitis with alcohol. Clinically, alcohol use predisposes to hypophosphatemia, and hypophosphatemia has been observed in some patients with acute pancreatitis. Because of abundant protein synthesis, the pancreas has high metabolic demands, and reduced mitochondrial function leads to organelle dysfunction and pancreatitis. We proposed, therefore, that phosphate deficiency might limit adenosine triphosphate synthesis and thereby contribute to alcohol-induced pancreatitis. METHODS: Mice were fed a low-phosphate diet (LPD) before orogastric administration of ethanol. Direct effects of phosphate and ethanol were evaluated in vitro in isolated mouse pancreatic acini. RESULTS: LPD reduced serum phosphate levels. Intragastric administration of ethanol to animals maintained on an LPD caused severe pancreatitis that was ameliorated by phosphate repletion. In pancreatic acinar cells, low-phosphate conditions increased susceptibility to ethanol-induced cellular dysfunction through decreased bioenergetic stores, specifically affecting total cellular adenosine triphosphate and mitochondrial function. Phosphate supplementation prevented ethanol-associated cellular injury. CONCLUSIONS: Phosphate status plays a critical role in predisposition to and protection from alcohol-induced acinar cell dysfunction and the development of acute alcohol-induced pancreatitis. This finding may explain why pancreatitis develops in only some individuals with heavy alcohol use and suggests a potential novel therapeutic approach to pancreatitis. Finally, an LPD plus ethanol provides a new model for studying alcohol-associated pancreatic injury.


Assuntos
Metabolismo Energético , Hipofosfatemia/complicações , Mitocôndrias/metabolismo , Pâncreas/metabolismo , Pancreatite Alcoólica/metabolismo , Fosfatos/deficiência , Trifosfato de Adenosina/metabolismo , Animais , Modelos Animais de Doenças , Etanol , Hipofosfatemia/metabolismo , Hipofosfatemia/prevenção & controle , Masculino , Camundongos Endogâmicos C57BL , Mitocôndrias/patologia , Pâncreas/patologia , Pancreatite Alcoólica/induzido quimicamente , Pancreatite Alcoólica/patologia , Pancreatite Alcoólica/prevenção & controle , Fosfatos/administração & dosagem , Índice de Gravidade de Doença , Técnicas de Cultura de Tecidos
2.
Pancreatology ; 15(4 Suppl): S18-22, 2015 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-26162756

RESUMO

Acute pancreatitis is a severe inflammatory disease with unacceptably high mortality and without specific therapy. Clinical studies revealed that energy supplementation of patients via enteral feeding decreases systemic infections, multi-organ failure and mortality. These clinical observations have been supported by in vitro and in vivo experimental studies which showed that the most common pancreatitis inducing factors, such as bile acids, ethanol and non-oxidative ethanol metabolites induce intracellular ATP depletion and mitochondrial damage both in pancreatic acinar and ductal cells. Notably, the in vitro supplementation of ATP prevented the cellular damage and restored cell functions in both cell types. These observations suggest that either prevention of mitochondrial damage or restoration of intracellular ATP level might provide therapeutical benefits.


Assuntos
Metabolismo Energético , Doenças Mitocondriais/metabolismo , Pancreatite Alcoólica/metabolismo , Doença Aguda , Trifosfato de Adenosina/metabolismo , Animais , Ácidos e Sais Biliares/metabolismo , Humanos
3.
Am J Physiol Gastrointest Liver Physiol ; 280(6): G1178-86, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11352811

RESUMO

This study was designed to develop an animal model of alcoholic pancreatitis and to test the hypothesis that the dose of ethanol and the type of dietary fat affect free radical formation and pancreatic pathology. Female Wistar rats were fed liquid diets rich in corn oil (unsaturated fat), with or without a standard or high dose of ethanol, and medium-chain triglycerides (saturated fat) with a high dose of ethanol for 8 wk enterally. The dose of ethanol was increased as tolerance developed, which allowed approximately twice as much alcohol to be delivered in the high-dose group. Serum pancreatic enzymes and histology were normal after 4 wk of diets rich in unsaturated fat, with or without the standard dose of ethanol. In contrast, enzyme levels were elevated significantly by the high ethanol dose. Increases were blunted significantly by dietary saturated fat. Fibrosis and collagen alpha1(I) expression in the pancreas were not detectable after 4 wk of enteral ethanol feeding; however, they were enhanced significantly by the high dose after 8 wk. Furthermore, radical adducts detected by electron spin resonance were minimal with the standard dose; however, the high dose increased carbon-centered radical adducts as well as 4-hydroxynonenal, an index of lipid peroxidation, significantly. Radical adducts were also blunted by approximately 70% by dietary saturated fat. The animal model presented here is the first to demonstrate chronic alcohol-induced pancreatitis in a reproducible manner. The key factors responsible for pathology are the amount of ethanol administered and the type of dietary fat.


Assuntos
Pancreatite Alcoólica/metabolismo , Pancreatite Alcoólica/patologia , Aldeídos/metabolismo , Animais , Doença Crônica , Gorduras na Dieta/farmacologia , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Etanol/farmacologia , Ácidos Graxos/farmacologia , Feminino , Fibrose , Radicais Livres/antagonistas & inibidores , Radicais Livres/metabolismo , Imuno-Histoquímica , Fígado/efeitos dos fármacos , Fígado/patologia , Pâncreas/efeitos dos fármacos , Pâncreas/metabolismo , Pâncreas/patologia , Proteínas/metabolismo , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA